Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Covington
US Army
Teva
Queensland Health
Daiichi Sankyo
Johnson and Johnson
Merck
Chubb
Fuji

Generated: October 19, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 202354

« Back to Dashboard
NDA 202354 describes ETOMIDATE, which is a drug marketed by Emcure Pharms Ltd, Aurobindo Pharma Ltd, Mylan Labs Ltd, Hikma Farmaceutica, Gland Pharma Ltd, Zydus Pharms Usa Inc, Luitpold, West-ward Pharms Int, and Par Sterile Products, and is included in ten NDAs. It is available from eleven suppliers. Additional details are available on the ETOMIDATE profile page.

The generic ingredient in ETOMIDATE is etomidate. There are six drug master file entries for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the etomidate profile page.

Summary for NDA: 202354

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:0
Formulation / Manufacturing:see details

Pharmacology for NDA: 202354

Physiological EffectGeneral Anesthesia

Suppliers and Packaging for NDA: 202354

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
ETOMIDATE
etomidate
INJECTABLE;INJECTION 202354 ANDA West-Ward Pharmaceuticals Corp 0143-9506 0143-9506-10 10 VIAL, SINGLE-DOSE in 1 CARTON (0143-9506-10) > 10 mL in 1 VIAL, SINGLE-DOSE (0143-9506-01)
ETOMIDATE
etomidate
INJECTABLE;INJECTION 202354 ANDA West-Ward Pharmaceuticals Corp 0143-9507 0143-9507-10 10 VIAL, SINGLE-DOSE in 1 CARTON (0143-9507-10) > 20 mL in 1 VIAL, SINGLE-DOSE (0143-9507-01)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength2MG/ML
Approval Date:Feb 25, 2016TE:APRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Cipla
Express Scripts
US Army
Teva
Argus Health
McKesson
Fuji
Chinese Patent Office
Daiichi Sankyo
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot